Please login to the form below

Blog: Wearables – The Technologist’s view

Patient insight is key to a successful solution. The wearable technology market has come of age, with the emergence of wearables into the consumer mainstream. Products like Apple Watch and Fitbit have set the stage for an acceptance of products that are more focused around specific health outcomes.
The wearable technology market has come of age, with the emergence of wearables into the consumer mainstream. Products like Apple Watch and Fitbit have set the stage for an acceptance of products that are more focused around specific health outcomes.

Pharmaceutical companies seeking to support patients “beyond the pill” are excited by this opportunity. The wearables market is projected to be worth $25bn by 2019 – so adopting the most effective approach to product development will be critical for maximising returns. Companies must also consider the effect of the wearable technology on the patient and whether it might meet the definition of a regulated medical device.



blog_images_Wearables


If more than a decade’s experience in developing digital patient engagement for pharmaceutical companies has taught us anything, it’s that bringing patients into the development process is a fundamental part of a successful project.

Whatever the product, whether it’s a device for blood analysis or an app to promote healthy living, it’s important to engage with potential users as early as possible in the development process, to understand who they are, their environment, their routine, habits and drivers. These are foundational insights which technologists neglect at their peril.

Glynn Godwin, our VP Interactive & Design, shares his thoughts on the wearable technology market with Pharma Market Europe here  

This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.





15th September 2016

Share

Tags

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared?
Ashfield
Ashfield joins the eyeforpharma webinar: The PSP Masterclass
Nagore Fernandez, Ashfield’s Head of Patient Services for EUCAN and Anna Baker, a Consultant in Health Psychology working closely with Ashfield, are joining an eyeforpharma panel debate: 'How Health Psychology drives winning Patient Support Programmes'. The webinar will take place Thursday 26th April at 9am New York, 2pm UK and 3pm Paris time.
Ashfield
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield
“Regulatory barriers to patient care; HCP perspectives on Medical Education
Ashfield Meetings & Events’ Andrew Moore and Lee-Anne Penn presented findings of new white paper – The Science Of Healthcare Professional Meetings at IPCAA
Ashfield
Download the Patient Support Programme Guidebook
Read our guidebook full of practical advice to design your next world-class Patient Support Programme (PSP) ...
Ashfield
Ashfield’s highlights from eyeforpharma Barcelona 2018
This week we were delighted to attend eyeforpharma Barcelona 2018 as global sponsors, where we ran a communications strategy workshop using our new Humanise framework and Nagore Fernandez, Head of Clinical Services for EUCAN, hosted part of the Commercial track.
Ashfield